Human Factors MD Inc. is pleased to welcome VeraLight as a new client.

About VeraLight

VeraLight is a medical instrumentation company taking a comprehensive approach to noninvasive diabetes screening. The company's mission is to help stem the tide of the worldwide diabetes epidemic by driving early diabetes detection, thus enabling initiation of therapies that can prevent diabetes or reduce its complications.

VeraLight is developing the Scout instrument to revolutionize screening for type 2 and pre-diabetes. Scout is substantially more convenient and accurate than current invasive screening methods. Scout employs fluorescence spectroscopy to noninvasively measure advanced glycation endproducts (AGEs) in the skin of a subject’s forearm. Skin AGEs are a well-known biomarker of diabetes, an excellent indicator of cumulative hyperglycemic exposure, and have been shown to predict the development of type 2 diabetes.

Human Factors MD
Making medical technology usable.™

[see other articles]